- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolution of Poxvirus Vaccines
Authors
Keywords
-
Journal
Viruses-Basel
Volume 7, Issue 4, Pages 1726-1803
Publisher
MDPI AG
Online
2015-04-08
DOI
10.3390/v7041726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
- (2015) Jerome H. Kim et al. Annual Review of Medicine
- Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of Type I and Type II Interferon-Binding Proteins
- (2015) Julie Delaloye et al. JOURNAL OF VIROLOGY
- Poxvirus-Based Vaccines for Cancer Immunotherapy: New Insights from Combined Cytokines/Co-Stimulatory Molecules Delivery and “Uncommon” Strains
- (2014) Valerio Izzi et al. Anti-Cancer Agents in Medicinal Chemistry
- Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
- (2014) Núria Busquets et al. ANTIVIRAL RESEARCH
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants
- (2014) Sharon E. Frey et al. Clinical and Vaccine Immunology
- Safety of Attenuated Smallpox Vaccine LC16m8 in Immunodeficient Mice
- (2014) Hiroyuki Yokote et al. Clinical and Vaccine Immunology
- Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection
- (2014) Adrian M. Di Bisceglie et al. GASTROENTEROLOGY
- Oncolytic vaccinia virotherapy for endometrial cancer
- (2014) Yu-Ping Liu et al. GYNECOLOGIC ONCOLOGY
- PROSTVAC® targeted immunotherapy candidate for prostate cancer
- (2014) Neal D Shore Immunotherapy
- Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF
- (2014) Weizhou Hou et al. INTERNATIONAL JOURNAL OF CANCER
- HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
- (2014) Pierre-Alexandre Bart et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter
- (2014) Kyong-Hwa Jun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The novel capripoxvirus vector lumpy skin disease virus efficiently boosts modified vaccinia Ankara human immunodeficiency virus responses in rhesus macaques
- (2014) W. A. Burgers et al. JOURNAL OF GENERAL VIROLOGY
- Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
- (2014) Paul A. Goepfert et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
- (2014) Susanne H. Hodgson et al. JOURNAL OF INFECTIOUS DISEASES
- Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells
- (2014) Laura Masuelli et al. Journal of Translational Medicine
- Virological and Immunological Characterization of Novel NYVAC-Based HIV/AIDS Vaccine Candidates Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as Virus-Like Particles
- (2014) Beatriz Perdiguero et al. JOURNAL OF VIROLOGY
- Deletion of the Vaccinia Virus N2L Gene Encoding an Inhibitor of IRF3 Improves the Immunogenicity of Modified Vaccinia Virus Ankara Expressing HIV-1 Antigens
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- Evolution of and Evolutionary Relationships between Extant Vaccinia Virus Strains
- (2014) Li Qin et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
- (2014) Susanne H Hodgson et al. MOLECULAR THERAPY
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton
- (2014) Chad R. Irwin et al. PLoS One
- The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
- (2014) Michele Tameris et al. PLoS One
- A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
- (2014) Karen R. Buttigieg et al. PLoS One
- Assessment of Humoral Immune Responses to Blood-Stage Malaria Antigens following ChAd63-MVA Immunization, Controlled Human Malaria Infection and Natural Exposure
- (2014) Sumi Biswas et al. PLoS One
- Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
- (2014) Vesna Tosic et al. PLoS One
- IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection
- (2014) S. A. Valkenburg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis
- (2014) Frank von Sonnenburg et al. VACCINE
- An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8+ T cells and antibody when expressed from modified vaccinia Ankara
- (2014) Bárbara R. Quinan et al. VACCINE
- Protective efficacy of a single immunization with capripoxvirus-vectored recombinant peste des petits ruminants vaccines in presence of pre-existing immunity
- (2014) Philippe Caufour et al. VACCINE
- Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins
- (2014) José Manuel Jaramillo Ortiz et al. VACCINE
- A novel vaccine against Porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection
- (2014) Hui-xing Lin et al. VETERINARY MICROBIOLOGY
- Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
- (2014) Arwen Altenburg et al. Viruses-Basel
- Enhancing poxvirus vectors vaccine immunogenicity
- (2014) Juan García-Arriaza et al. Human Vaccines & Immunotherapeutics
- Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
- (2014) Petra van den Doel et al. PLoS Neglected Tropical Diseases
- A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
- (2014) James Weger-Lucarelli et al. PLoS Neglected Tropical Diseases
- Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex
- (2014) Felix Wussow et al. PLoS Pathogens
- Poxviral-based vaccine elicits immunologic responses in prostate cancer patients
- (2014) Ravi A Madan et al. OncoImmunology
- Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees
- (2013) Charlotta Nilsson et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Detection of Infectious Laryngotracheitis Virus Antibodies by Glycoprotein-Specific ELISAs in Chickens Vaccinated with Viral Vector Vaccines
- (2013) Alecia Godoy et al. AVIAN DISEASES
- Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein
- (2013) Christelle Remy-Ziller et al. Clinical and Vaccine Immunology
- Clinical applications of attenuated MVA poxvirus strain
- (2013) Carmen Elena Gómez et al. Expert Review of Vaccines
- Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer
- (2013) Sepideh Gholami et al. FASEB JOURNAL
- CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
- (2013) S Parviainen et al. GENE THERAPY
- Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection
- (2013) Sean C. Elias et al. IMMUNOLOGY
- Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027)
- (2013) Pontiano Kaleebu et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- New vaccinia virus promoter as a potential candidate for future vaccines
- (2013) M. Di Pilato et al. JOURNAL OF GENERAL VIROLOGY
- Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
- (2013) R. P. Sumner et al. JOURNAL OF GENERAL VIROLOGY
- Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
- (2013) B. J. Ferguson et al. JOURNAL OF GENERAL VIROLOGY
- Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
- (2013) G. L. Smith et al. JOURNAL OF GENERAL VIROLOGY
- A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
- (2013) Anne Fournillier et al. JOURNAL OF INFECTIOUS DISEASES
- L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines
- (2013) Sole Maria Pacchioni et al. Journal of Translational Medicine
- High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome
- (2013) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
- (2013) F. Song et al. JOURNAL OF VIROLOGY
- Attenuated and Replication-Competent Vaccinia Virus Strains M65 and M101 with Distinct Biology and Immunogenicity as Potential Vaccine Candidates against Pathogens
- (2013) L. Sanchez-Sampedro et al. JOURNAL OF VIROLOGY
- IMMUNIZATION OF BLACK-TAILED PRAIRIE DOG AGAINST PLAGUE THROUGH CONSUMPTION OF VACCINE-LADEN BAITS
- (2013) Tonie E. Rocke et al. JOURNAL OF WILDLIFE DISEASES
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
- (2013) Feng Yu et al. MOLECULAR THERAPY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
- (2013) Caroline Ogwang et al. PLoS One
- TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
- (2013) Shivali Gupta et al. PLoS One
- Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review
- (2013) Marnie L. Elizaga et al. PLoS One
- Safety and Immunogenicity of DNA and MVA HIV-1 Subtype C Vaccine Prime-Boost Regimens: A Phase I Randomised Trial in HIV-Uninfected Indian Volunteers
- (2013) Sanjay Mehendale et al. PLoS One
- Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
- (2013) Juan García-Arriaza et al. PLoS One
- Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C
- (2013) Beatriz Perdiguero et al. PLoS One
- A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses
- (2013) Sonia T. Wennier et al. PLoS One
- A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants
- (2013) Muhammed O. Afolabi et al. PLoS One
- New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus
- (2013) Jörg Rohde et al. PLoS One
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic myxoma virus: The path to clinic
- (2013) Winnie M. Chan et al. VACCINE
- Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines
- (2013) Kateri Bertran et al. VACCINE
- Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
- (2013) Asisa Volz et al. VACCINE
- Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus
- (2013) Éric Niqueux et al. VACCINE
- Reflections on the early development of poxvirus vectors
- (2013) Bernard Moss VACCINE
- Recombinant MVA vaccines: dispelling the myths
- (2013) Matthew G. Cottingham et al. VACCINE
- Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects
- (2013) Simon J. Draper et al. VACCINE
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- Poxvirus vectors
- (2013) Joost H.C.M. Kreijtz et al. VACCINE
- Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol
- (2013) Hirotaka Sato et al. VACCINE
- Effects of different promoters on the virulence and immunogenicity of a HIV-1 Env-expressing recombinant vaccinia vaccine
- (2013) Mao Isshiki et al. VACCINE
- Evaluation of the pathogenicity of avipoxvirus strains isolated from wild birds in New Zealand and the efficacy of a fowlpox vaccine in passerines
- (2013) Hye Jeong Ha et al. VETERINARY MICROBIOLOGY
- Has horsepox become extinct?
- (2013) José Esparza VETERINARY RECORD
- Genomic analysis of vaccinia virus strain TianTan provides new insights into the evolution and evolutionary relationships between Orthopoxviruses
- (2013) Li Qin et al. VIROLOGY
- Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells
- (2013) Stefan Zimmerling et al. Virology Journal
- Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain
- (2013) Massimiliano Bissa et al. VIRUS RESEARCH
- A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection
- (2013) Elena López-Gil et al. PLoS Neglected Tropical Diseases
- Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
- (2013) J. L. Gulley et al. Cancer Immunology Research
- Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses
- (2012) Jiarong Xu et al. ARCHIVES OF VIROLOGY
- Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens
- (2012) Ariel Vagnozzi et al. AVIAN PATHOLOGY
- Protection against SHIV-KB9 Infection by Combining rDNA and rFPV Vaccines Based on HIV Multiepitope and p24 Protein in Chinese Rhesus Macaques
- (2012) Chang Li et al. Clinical & Developmental Immunology
- DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults
- (2012) Geoffrey J. Gorse et al. Clinical and Vaccine Immunology
- NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients
- (2012) Alexandre Harari et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer
- (2012) Robert J Amato et al. Future Oncology
- Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV-Exposed Infants in Uganda
- (2012) Kenneth Kintu et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Immunogenicity of the Tumor-Associated Antigenα-Fetoprotein Is Enhanced by a Fusion with a Transmembrane Domain
- (2012) Lucile Tran et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques
- (2012) Felix Wussow et al. JOURNAL OF VIROLOGY
- A New Rabies Vaccine Based on a Recombinant Orf Virus (Parapoxvirus) Expressing the Rabies Virus Glycoprotein
- (2012) Ralf Amann et al. JOURNAL OF VIROLOGY
- Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice
- (2012) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Deletion of Specific Immune-Modulatory Genes from Modified Vaccinia Virus Ankara-Based HIV Vaccines Engenders Improved Immunogenicity in Rhesus Macaques
- (2012) D. A. Garber et al. JOURNAL OF VIROLOGY
- ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic
- (2012) Julia L Rintoul et al. MOLECULAR THERAPY
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
- (2012) Susanne H. Sheehy et al. PLoS One
- Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
- (2012) Juliana Falivene et al. PLoS One
- High Quality Long-Term CD4+ and CD8+ Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of Infection
- (2012) Lucas Sánchez-Sampedro et al. PLoS One
- Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C
- (2012) Carmen Elena Gómez et al. PLoS One
- Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA
- (2012) Toritse Orubu et al. PLoS One
- Vaccine Efficacy against Malaria by the Combination of Porcine Parvovirus-Like Particles and Vaccinia Virus Vectors Expressing CS of Plasmodium
- (2012) Dolores Rodríguez et al. PLoS One
- Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens
- (2012) Beatriz Perdiguero et al. PLoS One
- The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks
- (2012) Cheng Qian et al. VACCINE
- Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2
- (2012) Hui-xing Lin et al. VACCINE
- Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice
- (2012) Brock Kingstad-Bakke et al. VACCINE
- Myxomavirus as a vector for the immunisation of sheep: Protection study against challenge with bluetongue virus
- (2012) Sokunthea Top et al. VACCINE
- Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
- (2012) Joel Meyer et al. VACCINE
- An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses
- (2012) H. El Garch et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs
- (2012) Jiarong Xu et al. VETERINARY MICROBIOLOGY
- Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response
- (2012) Fengjuan Wang et al. Virology Journal
- Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs
- (2012) Jiarong Xu et al. VIRUS RESEARCH
- Poxvirus vectors as HIV/AIDS vaccines in humans
- (2012) Carmen Elena Gómez et al. Human Vaccines & Immunotherapeutics
- Therapeutic vaccination to treat chronic infectious diseases
- (2012) Houda Boukhebza et al. Human Vaccines & Immunotherapeutics
- Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy
- (2012) Ivaylo Gentschev et al. Bioengineered
- A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
- (2011) Jonathan B Angel et al. AIDS
- Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer
- (2011) M Sathaiah et al. CANCER GENE THERAPY
- Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells
- (2011) Stefanie J. Mandl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
- (2011) Carmen E. Gomez et al. CURRENT GENE THERAPY
- Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
- (2011) Stephen R Walsh et al. Expert Review of Vaccines
- An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection
- (2011) Atchriya Hemachandra et al. Human vaccines & immunotherapeutics
- Serological responses in humans to the smallpox vaccine LC16m8
- (2011) B. F. Johnson et al. JOURNAL OF GENERAL VIROLOGY
- Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults
- (2011) J. S. Kennedy et al. JOURNAL OF INFECTIOUS DISEASES
- Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells
- (2011) Shari N. Gordon et al. JOURNAL OF INFECTIOUS DISEASES
- Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein
- (2011) Carlo Zanotto et al. Journal of Translational Medicine
- Deletion of Major Nonessential Genomic Regions in the Vaccinia Virus Lister Strain Enhances Attenuation without Altering Vaccine Efficacy in Mice
- (2011) J. Dimier et al. JOURNAL OF VIROLOGY
- DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa
- (2011) M. Perreau et al. JOURNAL OF VIROLOGY
- Genomic Analysis of the Vaccinia Virus Strain Variants Found in Dryvax Vaccine
- (2011) L. Qin et al. JOURNAL OF VIROLOGY
- Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
- (2011) Susanne H Sheehy et al. MOLECULAR THERAPY
- A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
- (2011) Tae-Ho Hwang et al. MOLECULAR THERAPY
- Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
- (2011) Jun Li et al. MOLECULAR THERAPY
- Treating Tumors With a Vaccinia Virus Expressing IFNβ Illustrates the Complex Relationships Between Oncolytic Ability and Immunogenicity
- (2011) Liang-Chuan S Wang et al. MOLECULAR THERAPY
- Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV Infection
- (2011) James S. Cavenaugh et al. PLoS One
- Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors
- (2011) Esther D. Quakkelaar et al. PLoS One
- Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification
- (2011) Darin S. Carroll et al. PLoS One
- A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells
- (2011) Michael A. Eller et al. PLoS One
- A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
- (2011) Juan García-Arriaza et al. PLoS One
- Improved NYVAC-Based Vaccine Vectors
- (2011) Karen V. Kibler et al. PLoS One
- A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus
- (2011) Alan G. Goodman et al. PLoS One
- Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand
- (2011) Punnee Pitisuttithum et al. PLoS One
- Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
- (2011) B. J. Flynn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
- (2011) David W. Porter et al. VACCINE
- Vaccinia virus as a vaccine delivery system for marsupial wildlife
- (2011) Martin L. Cross et al. VACCINE
- The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
- (2011) Karen L. Denzler et al. VACCINE
- Evaluation of recombinant fowlpox virus expressing infectious bronchitis virus S1 gene and chicken interferon-γ gene for immune protection against heterologous strains
- (2011) Xing-Ming Shi et al. VACCINE
- Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
- (2011) Karen L. Denzler et al. VACCINE
- Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
- (2011) Kristina E. Rehm et al. VACCINE
- A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects☆☆☆
- (2011) Michael C. Keefer et al. VACCINE
- Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain
- (2011) J.M. Minke et al. VACCINE
- A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV)
- (2011) Joerg Rohde et al. VACCINE
- The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus
- (2011) Karen L. Denzler et al. VACCINE
- Recombinant MVA Expressing Secreted Glycoprotein D of BoHV-1 Induces Systemic and Mucosal Immunity in Animal Models
- (2011) María Florencia Ferrer et al. VIRAL IMMUNOLOGY
- A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV)
- (2011) Yen-Ju Shen et al. Virology Journal
- Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
- (2011) Simon H Bridge et al. Virology Journal
- Avipoxviruses: infection biology and their use as vaccine vectors
- (2011) Simon C Weli et al. Virology Journal
- TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)
- (2011) Asha Jayakumar et al. PLoS Neglected Tropical Diseases
- Canarypox and fowlpox viruses as recombinant vaccine vectors: A biological and immunological comparison
- (2010) Carlo Zanotto et al. ANTIVIRAL RESEARCH
- High Level of Protection Induced by Two Fowlpox Vector Vaccines Against a Highly Pathogenic Avian Influenza H5N1 Challenge in Specific-Pathogen-Free Chickens
- (2010) Michel Bublot et al. AVIAN DISEASES
- Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice
- (2010) Laura Masuelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
- (2010) Hidenobu Ishizaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Characterization of Host Responses against a Recombinant Fowlpox Virus-Vectored Vaccine Expressing the Hemagglutinin Antigen of an Avian Influenza Virus
- (2010) H. R. Hghihghi et al. Clinical and Vaccine Immunology
- Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine
- (2010) R. K. Soi et al. Clinical and Vaccine Immunology
- Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) R. J. Amato et al. CLINICAL CANCER RESEARCH
- MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays
- (2010) S Kutscher et al. GENE THERAPY
- Prime-boost vectored malaria vaccines: Progress and prospects
- (2010) Adrian V. S. Hill et al. Human vaccines & immunotherapeutics
- Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression
- (2010) Hidenobu Ishizaki et al. JOURNAL OF IMMUNOTHERAPY
- Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma
- (2010) Thorsten U. Vogel et al. JOURNAL OF IMMUNOTHERAPY
- Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
- (2010) Marissa B. Wilck et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax
- (2010) Michael S. Seaman et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
- (2010) Rodryg Ramlau et al. Journal of Thoracic Oncology
- Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits
- (2010) Antonia Radaelli et al. Journal of Translational Medicine
- Vaccine-Induced Control of Viral Shedding following Rhesus Cytomegalovirus Challenge in Rhesus Macaques
- (2010) K. Abel et al. JOURNAL OF VIROLOGY
- Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses
- (2010) K. Baur et al. JOURNAL OF VIROLOGY
- Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice
- (2010) C. Meisinger-Henschel et al. JOURNAL OF VIROLOGY
- Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS
- (2010) S. Guerra et al. JOURNAL OF VIROLOGY
- Potent Oncolytic Activity of Raccoonpox Virus in the Absence of Natural Pathogenicity
- (2010) Laura Evgin et al. MOLECULAR THERAPY
- Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
- (2010) Sandhya Vasan et al. PLoS One
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
- (2010) Juan García-Arriaza et al. PLoS One
- MIG and the Regulatory Cytokines IL-10 and TGF-β1 Correlate with Malaria Vaccine Immunogenicity and Efficacy
- (2010) Susanna J. Dunachie et al. PLoS One
- A safety assessment of a fowlpox-vectored Mycoplasma gallisepticum vaccine in chickens
- (2010) G. Z. Zhang et al. POULTRY SCIENCE
- Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities
- (2010) T. J. Merkel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing
- (2010) Z. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine
- (2010) Koert J. Stittelaar et al. VACCINE
- A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers
- (2010) Hee-Chang Jang et al. VACCINE
- Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
- (2010) Joseph N. Brewoo et al. VACCINE
- Construction and immunogenicity of a recombinant fowlpox vaccine coexpressing S1 glycoprotein of infectious bronchitis virus and chicken IL-18
- (2010) Hong-Ying Chen et al. VACCINE
- The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
- (2010) Feng Feng et al. VACCINE
- A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep
- (2010) Weiye Chen et al. VACCINE
- Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression
- (2010) Magdalena Krupa et al. VACCINE
- Consumption of Baits Containing Raccoon Pox-Based Plague Vaccines Protects Black-Tailed Prairie Dogs (Cynomys ludovicianus)
- (2010) Tonie E. Rocke et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses
- (2010) Edwin R. Manuel et al. VIROLOGY
- Orthopoxvirus Genome Evolution: The Role of Gene Loss
- (2010) Robert Curtis Hendrickson et al. Viruses-Basel
- Poxvirus vector-based HIV vaccines
- (2010) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- Vaccinia virus vaccines: Past, present and future
- (2009) Bertram L. Jacobs et al. ANTIVIRAL RESEARCH
- The immunologic aspects of poxvirus oncolytic therapy
- (2009) Andrea Worschech et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model
- (2009) C. A. Meseda et al. Clinical and Vaccine Immunology
- Correlates of protection efficacy induced by vaccinia virus-specific CD8+T-cell epitopes in the murine intranasal challenge model
- (2009) Magdalini Moutaftsi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8
- (2009) Tomoya Saito JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice
- (2009) L. L. M. Poon et al. JOURNAL OF IMMUNOLOGY
- Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax)
- (2009) Robert J. Amato et al. JOURNAL OF IMMUNOTHERAPY
- Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins
- (2009) Eleana Pozzi et al. JOURNAL OF VIROLOGICAL METHODS
- Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
- (2009) P. Mooij et al. JOURNAL OF VIROLOGY
- Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression
- (2009) M. H. Lehmann et al. JOURNAL OF VIROLOGY
- Intranodal Immunization With a Vaccinia Virus Encoding Multiple Antigenic Epitopes and Costimulatory Molecules in Metastatic Melanoma
- (2009) Michel Adamina et al. MOLECULAR THERAPY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
- (2009) Xiaoxing Huang et al. PLoS One
- Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies
- (2009) David A. Garber et al. PLoS One
- Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection
- (2009) I. Ramos et al. VACCINE
- Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
- (2009) Tonie E. Rocke et al. VACCINE
- Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs
- (2009) Constantinos S. Kyriakis et al. VACCINE
- A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
- (2009) Rajesh T. Gandhi et al. VACCINE
- Definition of epitopes and antigens recognized by vaccinia specific immune responses: Their conservation in variola virus sequences, and use as a model system to study complex pathogens
- (2009) Alessandro Sette et al. VACCINE
- Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNγ
- (2009) Yun-Feng Wang et al. VACCINE
- Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
- (2009) Alan J. Guthrie et al. VACCINE
- A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
- (2009) Alfred von Krempelhuber et al. VACCINE
- Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs
- (2009) E.M.A. van Rooij et al. VACCINE
- Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC®) vaccination
- (2009) Gisela Soboll et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus
- (2008) Chuanling Qiao et al. ANTIVIRAL RESEARCH
- Protection of Chickens from Newcastle Disease and Infectious Laryngotracheitis with a Recombinant Fowlpox Virus Co-Expressing the F, HN Genes of Newcastle Disease Virus and gB Gene of Infectious Laryngotracheitis Virus
- (2008) Hui-Ling Sun et al. AVIAN DISEASES
- Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
- (2008) J Foloppe et al. GENE THERAPY
- MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure
- (2008) R. Dreicer et al. INVESTIGATIONAL NEW DRUGS
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence
- (2008) A. S. Fahy et al. JOURNAL OF GENERAL VIROLOGY
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
- (2008) Yujuan Yue et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
- (2008) Matthew G. Cottingham et al. PLoS One
- Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus
- (2008) P. L. Earl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mucosal Administration of Completely Non-Replicative Vaccinia Virus Recombinant Dairen I strain Elicits Effective Mucosal and Systemic Immunity
- (2008) N. Yoshino et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
- (2008) Jun Liu et al. VACCINE
- Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
- (2008) Kaifan Dai et al. VACCINE
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
- Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination
- (2008) Garilyn M. Jentarra et al. VACCINE
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
- A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
- (2008) Kai Schulze et al. VACCINE
- Prime–boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI
- (2008) M. Steensels et al. VACCINE
- A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
- (2008) Connor Carson et al. VACCINE
- A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse
- (2008) H. El Garch et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector
- (2008) Z. Wang et al. VIROLOGY
- Eimeria tenella: Construction of a recombinant fowlpox virus expressing rhomboid gene and its protective efficacy against homologous infection
- (2007) Guilian Yang et al. EXPERIMENTAL PARASITOLOGY
- Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response
- (2007) I. Ramos et al. VACCINE
- Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines
- (2007) Linda S. Wyatt et al. VACCINE
- Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18
- (2007) Mingxiao Ma et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search